Martha Llamas, LMSW
Martha Llamas is a bilingual licensed master social worker in the Cleft and Craniofacial Center at Barrow Neurological Institute. She is licensed by the State of Arizona Board of Behavioral Health Examiners.
Ms. Llamas’ expertise includes individualized treatment planning and interventions to support patients and families with medical, emotional, and socioeconomic needs.
Ms. Llamas earned her bachelor’s and master’s degrees in social work from Arizona State University.
For more information or to request an appointment with Ms. Llamas, please call (602) 406-3560.
Ryan Pevey, MS
Ryan Pevey graduated with a Bachelor of Science in Cellular Biology and Evolution and a Master of Science in Biology, both from the University of Northern Colorado. His research interest lies in conditions of the brain involving complex genetics and how these play a role in varying neurodegenerative diseases. In the lab, Mr. Pevey’s research focuses on investigating the role of TDP-43 in RNA splicing, and how these functions are dysregulated in ALS, FTD, and Alzheimer’s disease.
Lynette Bustos, BS
Lynette Bustos graduated from The University of New Mexico with a Bachelor of Science. Her research interests lie in determining mechanisms of neuronal degeneration that are specific to neurodegenerative disease pathology. Ms. Bustos is particularly interested in understanding how disruptions in the neuron-glia and glia-glia communication networks result in neuronal death, and how those disruptions contribute to disease onset and pathology. Her current project involves investigating the role of cortical astrocytes in the neurodegeneration of cortical neurons leading to dementia in C9orf72-FTD/ALS.
Lauren Gittings, PhD
Lauren Gittings graduated from the University of Bath (U.K.) with a Bachelor of Science in Natural Sciences in 2014. She then went on to do her graduate studies at University College London (U.K.), where she used iPSC models and post-mortem tissue to study the role of the dipeptide repeat proteins in C9orf72-linked FTD and ALS. Dr. Gittings graduated with a PhD in Neurodegeneration in 2018 and then moved to the U.S. to join the Sattler lab. Her research interests lie in identifying molecular and cellular signatures that influence the development of cognitive impairment in ALS patients carrying the C9orf72 mutation.